Episode Details

In the latest TDR Cannabis in Five, host Shadd Dales breaks down the chaos out of Washington this week, and whether or not Attorney General Pam Bondi’s heated congressional hearing put cannabis rescheduling at risk?After a chaotic five-hour session focused largely on the DOJ’s handling of the Epstein files, political pressure around Bondi intensified. Critics questioned her leadership. Supporters called it a political ambush. But for cannabis investors and policy watchers, the real question is whether this drama impacts the federal rescheduling timeline.This episode separates optics from process.The HHS recommendation has already been submitted. The DEA’s scientific and administrative review is ongoing. And legally, the rescheduling process does not collapse if leadership changes at the DOJ. If necessary, an Acting Attorney General would have full authority to sign off on the rule.So does this create delay? Or is the machinery already too far in motion?TDR Cannabis in Five focuses on facts, not noise — walking through what actually changes, what doesn’t, and what serious cannabis investors should be watching next as Washington volatility intersects with drug policy reform.#TDRCannabisInFive #CannabisRescheduling #PamBondi#DOJ #CannabisPolicy #DEA#HHS #CannabisNews#TrumpAdministration#EpsteinFiles #BondiHearingWant to see more Cannabis Reform videos?🎬    • Was Trump Really “Poorly Advised” on Canna...  🎬    • Virginia Is Finally Getting Serious About ...  🎬    • Why Washington Still Bans Homegrown Cannab...  🎬    • Who’s Trying to Undo Legal Cannabis? | TDR...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:

Listen Now